FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
ABBOTINDIA Share Price Target
Abbott India Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
ABBOTINDIA Share Price *
12,762.05 -39.25 (-0.31%)
* (quote may be delayed)
ABBOTINDIA Share Price Forecast - Consensus
| No. of reports in last year | 2 |
| No. of analysts | 1 |
| Average Consensus Forecast | 12395.00 |
| Consensus Potential | -6.65% |
ABBOTINDIA Share Price Target - Broker Reports - 2019
ICICIdirect.com
25-Nov-19
Price @ Call: 12572.1
Target: 14600
BUY
H1FY20 revenues grew 12.6% YoY to | 2053.7 crore, mainly due to strong growth in key therapies & power brands. EBITDA margins improved 169 bps YoY to 18.4% mainly due to better operational leverage and impact of Ind- As 116. Net profit grew 34.2% YoY to | 295.3 crore. Delta vis-à-vis EBITDA was mainly due to lower tax rate.
ICICIdirect.com
26-Aug-19
Price @ Call: 8799.1
Target: 10190
BUY
The domestic pharma industry is expected to grow in the range of 9-11% per annum. Issues such as NLEM and other regulatory aspects are mostly in the price. On the flip side, the looming threat of Jan Aushadhi and trade generics are some head winds at this juncture. However, we continue to believe in Abbott’s strong growth track in power brands and capability ofnew launches on a fairly consistent basis (100 products in the last ten years). We expect revenues, EBITDA and PAT to grow at ~12%, 14% and 17% CAGR, respectively, in FY19-21E. We arrive at a target price of Rs 10190 based on 35x FY21 EPS of Rs 291.
ABBOTINDIA Share Price Target - Broker Reports - 2018
Centrum
12-Oct-18
Price @ Call: 7465.48
Target: 7250
HOLD
ABBOTINDIA Share Price Target - Broker Reports - 2017
ICICIdirect.com
20-Dec-17
Price @ Call: 5389
Target: 6850
BUY
Centrum
6-Feb-17
Price @ Call: 4597
Target: 5380
BUY